Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Private equity radiology investor reaches agreement with FTC over alleged anticompetitive tactics
US Radiology Specialists backer Welsh, Carson, Anderson & Stowe blasted the proposed order Friday, labeling it as symbolic and politically motivated.
Congressional candidate physician sues hospital and doctor for death of father
Some of the claims in the lawsuit, brought against Novant Health by Kyle Horton, MD, are backed by a report from the North Carolina Department of Health and Human Services.
DEA wants to permanently anchor some COVID-era prescription regulations
The Drug Enforcement Administration is proposing the adoption of some COVID-era prescription practices around certain controlled substances. The agency published a framework to guide any such changes Jan. 17.
FDA regulator examines AI's growing influence in cardiology
Stephen Browning, the FDA's assistant director of hemodynamics and heart failure diagnostics, spoke with Cardiovascular Business about the agency's perspective on AI-enabled cardiovascular devices and many other topics.
RadNet sees potential midsize and larger acquisitions on its horizon
Leaders with the Los Angeles-based, publicly traded imaging center operator spoke Jan. 15 at the 43rd annual JP Morgan Healthcare Conference in San Francisco.

US Radiology Specialists hires executive from its private equity backer to fill out C-suite

Paul Taheri, MD, MBA, will serve as chief clinical officer following his time as clinical partner at Welsh, Carson, Anderson & Stowe.

Radiology societies issue ‘call to action’ against looming threat to physician offices’ financial viability

ACR, SIR, ASTRO and others are concerned about about forthcoming cuts in the Medicare Physician Fee Schedule that will impact specialties with high equipment costs.

ChatGPT effectively simplifies radiology reports, presents 'real opportunity' to better inform patients

Radiology reports are typically written in language well above the average American adult’s eighth grade reading level, making them a source of confusion for patients.

Interventional radiology among 4 specialties with the greatest growth in claims volume since 2018

The specialty saw an 83% uptick in billing between 2018 and 2022, publicly traded data and analytics firm Definitive Healthcare reported.

Do clinicians want radiologists' management advice? Interviews shed some light on 'unwanted' recommendations

Clinicians only want the information they need to make treatment decisions, rather than advice on what actions they should take, the survey found.

healthcare value value-based care money dollar

Bitterroot Bio, a new biotech company launched by physicians and industry veterans, raises $145M

The new company formed in 2021, but waited until now to publicly launch. Its founders included two Stanford University physicians.

The Wattson temporary pacing guidewire from Teleflex

FDA clears new guidewire used for valve delivery and ventricular pacing during TAVR, BAV procedures

The device, now on display at TVT 2023 in Phoenix, is scheduled to begin hitting the market in the months ahead.

State abortion restrictions do not appear to impact radiology residency applications

Radiologists have expressed concern that the Supreme Court’s controversial decision to overturn Roe v. Wade would exacerbate physician shortages.

Management

Private equity radiology investor reaches agreement with FTC over alleged anticompetitive tactics

Congressional candidate physician sues hospital and doctor for death of father

DEA wants to permanently anchor some COVID-era prescription regulations

FDA regulator examines AI's growing influence in cardiology

RadNet sees potential midsize and larger acquisitions on its horizon